Uterine artery embolization is emerging as a primary treatment for symptomatic uterine fibroids. This procedure is performed electively but occasionally is performed emergently in the setting of life-threatening hemorrhage. Most interventional radiologists performing this procedure use ultrasound or magnetic resonance imaging (MRI) for preprocedure evaluation and follow-up. Two case studies report the sonographic and color flow Doppler findings before, immediately after, and 3 months after uterine fibroid embolization (UFE) in an emergent UFE and an elective case. Angiographic and MRI correlation are also provided.
Ravina J , Herbreteau D, Ciraru-Vigneron N, at al: Arterial embolization to treat uterine myomata. Lancet1995;346:671–672.
2.
Goodwin S , Vedantham S, McLucas B, et al: Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol1997;8:517–526.
3.
SCVIR survey 1999 : preparatory brief for FDA Obstetrics & Gynecology Devices Panel. SCVIR News1999;12(6).
4.
Worthington-Kirsch RL , Popky GL, Hutchins FL: Uterine artery embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology1998;208:625–629.
5.
Lipman JC : Uterine artery embolization for the treatment of symptomatic uterine fibroids: a review. Appl Radiol2000;29(7):15–20.
